Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Prices Offering of Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market on Thursday that it has priced an offering of senior notes.

The offering of $400 million aggregate principal amount of 3.5 percent senior notes due 2016 have an issue price of 99.84 percent of their face value. $400 million aggregate principal amount of 5 percent senior notes due 2021 have an issue price of 99.556 percent of their face value.

The issuance of the notes is anticipated to close on Dec. 14. The notes will pay on a semi-annual basis. Proceeds from the offering will be directed at general corporate use, which may include repayment of existing loans, the company said.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.